Mainstream processors and most business banks treat SARMs as a restricted category. A small number of specialist providers will assess research-use-only suppliers on their merits when the business is disclosed upfront.
Mainstream payment platforms and most business banks treat SARMs in the same way as peptides: as a restricted category. A small number of specialist acquirers and banking providers will assess suppliers that lawfully sell for research use only, provided the business model is disclosed upfront and the website is compliant. We pre-qualify your set-up against their current criteria, then introduce you only where there is appetite.
Mainstream payment platforms commonly list SARMs alongside other research chemicals in their restricted business lists.
Accounts opened without full disclosure tend to be closed once product pages or transaction descriptions are reviewed, often with funds held.
Any suggestion of human use, dosing or performance claims is usually enough for a provider to decline.
We match UK research compound suppliers with providers that assess the category knowingly, and prepare the application so it is reviewed properly the first time.
Card acquiringVisa and Mastercard acceptance through acquirers that assess research-use-only suppliers.
Business bankingNamed GBP and multi-currency accounts with providers that know what you sell.
Website readiness reviewResearch-use-only terms, product descriptions and policies checked against acquirer requirements before you apply.
Banking and processing togetherSettlement into an account set up for your business model, so one does not undermine the other.
Providers move fastest when the file is complete on day one. Have these ready before you apply.
Company documentsCertificate of incorporation, registered address and a short description of what you sell and to whom.
Ownership and IDPassport or ID and proof of address for every owner with 25% or more, and for directors.
Processing historyYour last 3 to 6 months of processing statements, if you have them, including chargeback and refund levels.
Bank statementsRecent business bank statements showing how money moves in and out of the business.
A compliant websiteFull company details, terms, refund and shipping policies, and accurate product descriptions.
Volumes and flowsExpected monthly volume, average transaction size, main customer countries and settlement currency.
Product evidenceCertificates of analysis and supplier documentation where available, and research-use-only labelling.
Full list by sector: high-risk merchant documents checklist →
A new UK store selling research compounds has been declined by every mainstream platform it tried.
An established seller's processor closed the account after reviewing product pages, and funds are held.
A supplier sells both peptides and SARMs and needs one stable set-up for the full range.
Possibly, through specialist acquirers that assess research-use-only suppliers knowingly. Appetite is narrower than for peptides, so preparation and full disclosure matter.
Most mainstream platforms list them as restricted because of the risk of human-use marketing and regulatory change. Specialist providers look at how you sell, not just what you sell.
Clear research-use-only positioning, no dosing or human-use content, accurate product descriptions, certificates of analysis where relevant, and full company details and policies.
No. We only work with lawful businesses selling research compounds for research use only.
Yes. We look at banking and card processing together so settlement goes into an account that is set up for your business.
Give us the detail upfront (volume, set-up, what has been declined) and we can check provider appetite before we speak. We will assess whether there is a suitable provider match and come back to you directly. No obligation, no hard sell.
Have a client in this sector?If you're an EMI, MSB, payment consultant, or adviser with clients in this space you can't service directly, we have a structured introducer arrangement.